TickerFactsScreenerDevelopers

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$2.07M2011: -$2.22M2012: -$2.94M2013: -$4.05M2014: -$4.49M2016: -$5.86M2017: -$2.36M2018: -$12.39M2019: -$11.25M2020: -$35.19M2021: -$26.27M2022: -$19.32M2023: -$20.46M2024: -$9.09M2025: -$6.97M-$6.97M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.97M+23.3%
2024-$9.09M+55.6%
2023-$20.46M-5.9%
2022-$19.32M+26.4%
2021-$26.27M+25.4%
2020-$35.19M-212.9%
2019-$11.25M+9.2%
2018-$12.39M-424.0%
2017-$2.36M+59.6%
2016-$5.86M—
2014-$4.49M-10.7%
2013-$4.05M-38.1%
2012-$2.94M-32.0%
2011-$2.22M-7.4%
2010-$2.07M—